Our results do not preclude the possibility of a role for PTPRN2 in constitutive secretion utilized by breast cancer cells, as we observed defects in invasion, a process dependent on secretion of extracellular modifying proteins, upon depletion of PTPRN2 in highly metastatic breast cancer cells. The gene discussed is PTPRN2; the disease is breast carcinoma.